Is avidity Biosciences (RNA) a publicly traded stock?

Avidity Biosciences, Inc. is currently listed on NASDAQ under RNA. One share of RNA stock can currently be purchased for approximately $7.54. Is Avidity Biosciences, Inc. a publicly traded stock? Yes, Avidity Biosciences, Inc. is publicly traded and listed as RNA on the NASDAQ. It is currently being traded for approximately $7.54.

Who owns avidity?

We’re owned by Avidity Group Ltd, who provide the investment and financial firepower to help us achieve our goals. We operate out of the UK and Ireland, but our reach is extended into Europe through our partnership with Sales Service International (SSI).

Does Bristol Myers buy avidity?

Bristol Myers has agreed to pay Avidity $60 million in cash and will also purchase about $40 million of Avidity common stock at $7.88 a share. Avidity Biosciences Inc. RNA said Tuesday it's expanding its cardiovascular collaboration with Bristol Myers Squibb Co. BMY in a deal that will see Avidity receive $100 million upfront with the potent...